BullFrog AI Announced Significant Advancements In Its Ongoing Collaboration With The Lieber Institute For Brain Development For Specific Molecular Pathways Associated With Bipolar Disorder, Enabling The Identification Of New Candidate Drug Targets
BullFrog AI Announced Significant Advancements In Its Ongoing Collaboration With The Lieber Institute For Brain Development For Specific Molecular Pathways Associated With Bipolar Disorder, Enabling The Identification Of New Candidate Drug Targets
BullFrog人工智能宣佈在與利伯腦部發展研究所的持續合作中取得了重大進展，針對與雙相情感障礙相關的特定分子通路，能夠識別新的候選藥物靶點。
BullFrog AI Announced Significant Advancements In Its Ongoing Collaboration With The Lieber Institute For Brain Development For Specific Molecular Pathways Associated With Bipolar Disorder, Enabling The Identification Of New Candidate Drug Targets
BullFrog人工智能宣佈在與利伯腦部發展研究所的持續合作中取得了重大進展，針對與雙相情感障礙相關的特定分子通路，能夠識別新的候選藥物靶點。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。